J 2021

Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy

RIAD, Abanoub, Huthaifa ABDULQADER, Mariana MORGADO, Silvi DOMNORI, Michal KOŠČÍK et. al.

Základní údaje

Originální název

Global Prevalence and Drivers of Dental Students’ COVID-19 Vaccine Hesitancy

Autoři

RIAD, Abanoub (818 Egypt, garant, domácí), Huthaifa ABDULQADER, Mariana MORGADO, Silvi DOMNORI, Michal KOŠČÍK (203 Česká republika, domácí), José João MENDES, Miloslav KLUGAR (203 Česká republika, domácí) a Elham KATEEB

Vydání

Vaccines, Basel, MDPI, 2021, 2076-393X

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30102 Immunology

Stát vydavatele

Švýcarsko

Utajení

není předmětem státního či obchodního tajemství

Odkazy

Impakt faktor

Impact factor: 4.961

Kód RIV

RIV/00216224:14110/21:00121676

Organizační jednotka

Lékařská fakulta

UT WoS

000666515400001

Klíčová slova anglicky

COVID-19 vaccines; cross-sectional studies; decision making; dental education; dental students; international association of dental students; mass vaccination; multicentre study; social determinants of health

Příznaky

Mezinárodní význam, Recenzováno
Změněno: 20. 8. 2021 11:10, Mgr. Tereza Miškechová

Anotace

V originále

Background: Acceleration of mass vaccination strategies is the only pathway to overcome the COVID-19 pandemic. Healthcare professionals and students have a key role in shaping public opinion about vaccines. This study aimed to evaluate the attitudes of dental students globally towards COVID-19 vaccines and explore the potential drivers for students’ acceptance levels. Methods: A global cross-sectional study was carried out in February 2021 using an online questionnaire. The study was liaised by the scientific committee of the International Association of Dental Students (IADS), and data were collected through the national and local coordinators of IADS member organizations. The dependent variable was the willingness to take the COVID-19 vaccine, and the independent variables included demographic characteristics, COVID-19-related experience, and the drivers of COVID-19 vaccine-related attitude suggested by the WHO SAGE. Results: A total of 6639 students from 22 countries, representing all world regions, responded to the questionnaire properly. Their mean age was 22.1 ± 2.8 (17–40) years, and the majority were females (70.5%), in clinical years (66.8%), and from upper-middle-income economies (45.7%). In general, 22.5% of dental students worldwide were hesitant, and 13.9% rejected COVID-19 vaccines. The students in low- and lower-middle-income (LLMI) economies had significantly higher levels of vaccine hesitancy compared to their peers in upper-middle- and high-income (UMHI) economies (30.4% vs. 19.8%; p < 0.01). Conclusions: The global acceptance level of dental students for COVID-19 vaccines was suboptimal, and their worrisome level of vaccine hesitancy was influenced by the socioeconomic context where the dental students live and study. The media and social media, public figures, insufficient knowledge about vaccines, and mistrust of governments and the pharmaceutical industry were barriers to vaccination. The findings of this study call for further implementation of epidemiology (infectious diseases) education within undergraduate dental curricula.

Návaznosti

LTC20031, projekt VaV
Název: Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic
Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Towards an International Network for Evidence-based Research in Clinical Health Research in the Czech Republic, INTER-COST
MUNI/A/1608/2020, interní kód MU
Název: Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
Investor: Masarykova univerzita, Prohlubování znalostí v oblasti zdravotních rizik a benefitů výživy, prostředí a životního stylu III
MUNI/IGA/1543/2020, interní kód MU
Název: Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic (Akronym: Evidence-Based Practice in Czechia)
Investor: Masarykova univerzita, Evidence-based Practice of Healthcare Professionals and Students in the Czech Republic